<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The <z:chebi fb="1" ids="24848">inositol</z:chebi> 1,4,5-trisphosphate receptor (InsP3R) mediates Ca(2+) signaling in epithelia and regulates cellular functions such as secretion, <z:mpath ids='MPATH_3'>apoptosis</z:mpath> and cell proliferation </plain></SENT>
<SENT sid="1" pm="."><plain>Loss of one or more InsP3R isoform has been implicated in disease processes such as <z:hpo ids='HP_0001396'>cholestasis</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>Here we examined whether gain of expression of InsP3R isoforms also may be associated with development of disease </plain></SENT>
<SENT sid="3" pm="."><plain>Expression of <z:hpo ids='HP_0000001'>all</z:hpo> three InsP3R isoforms was evaluated in tissue from colorectal <z:mp ids='MP_0002038'>carcinomas</z:mp> surgically resected from 116 patients </plain></SENT>
<SENT sid="4" pm="."><plain>Type I and II InsP3Rs were seen in both <z:mpath ids='MPATH_458'>normal</z:mpath> colorectal mucosa and <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e>, while type III InsP3R was observed only in <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> </plain></SENT>
<SENT sid="5" pm="."><plain>Type III InsP3R expression in the advancing margins of <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> correlated with depth of invasion, lymph node <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e>, <z:e sem="disease" ids="C0494165" disease_type="Neoplastic Process" abbrv="">liver metastasis</z:e>, and TNM stage </plain></SENT>
<SENT sid="6" pm="."><plain>Heavier expression of type III InsP3R also was associated with decreased 5-year survival </plain></SENT>
<SENT sid="7" pm="."><plain>shRNA knockdown of type III InsP3R in CACO-2 <z:hpo ids='HP_0003003'>colon cancer</z:hpo> cells enhanced <z:mpath ids='MPATH_3'>apoptosis</z:mpath>, while over-expression of the receptor <z:mp ids='MP_0006043'>decreased apoptosis</z:mp> </plain></SENT>
<SENT sid="8" pm="."><plain>Thus, type III InsP3R becomes expressed in <z:hpo ids='HP_0003003'>colon cancer</z:hpo>, and its expression level is directly related to <z:hpo ids='HP_0000718'>aggressiveness</z:hpo> of the <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e>, which may reflect inhibition of <z:mpath ids='MPATH_3'>apoptosis</z:mpath> by the receptor </plain></SENT>
<SENT sid="9" pm="."><plain>These findings suggest a previously unrecognized role for Ca(2+) signaling via this InsP3R isoform in <z:hpo ids='HP_0003003'>colon cancer</z:hpo> </plain></SENT>
</text></document>